CH464935A - Verfahren zur Herstellung neuer Chinazolinonderivate - Google Patents
Verfahren zur Herstellung neuer ChinazolinonderivateInfo
- Publication number
- CH464935A CH464935A CH936465A CH936465A CH464935A CH 464935 A CH464935 A CH 464935A CH 936465 A CH936465 A CH 936465A CH 936465 A CH936465 A CH 936465A CH 464935 A CH464935 A CH 464935A
- Authority
- CH
- Switzerland
- Prior art keywords
- production
- quinazolinone derivatives
- new
- new quinazolinone
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2813865 | 1965-05-12 | ||
| JP2834265 | 1965-05-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH464935A true CH464935A (de) | 1968-11-15 |
Family
ID=26366189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH936465A CH464935A (de) | 1965-05-12 | 1965-07-05 | Verfahren zur Herstellung neuer Chinazolinonderivate |
Country Status (4)
| Country | Link |
|---|---|
| BE (1) | BE666424A (enExample) |
| CH (1) | CH464935A (enExample) |
| DE (1) | DE1620284C3 (enExample) |
| FR (1) | FR4491M (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6258918B2 (ja) * | 2012-04-10 | 2018-01-10 | アンジー ファーマスーティカル カンパニー リミテッドＡｎｎｊｉ Ｐｈａｒａｍａｃｅｕｔｉｃａｌ Ｃｏ．， Ｌｔｄ． | ヒストンデアセチラーゼ（ｈｄａｃｓ）阻害剤 |
-
1965
- 1965-07-05 BE BE666424D patent/BE666424A/xx unknown
- 1965-07-05 CH CH936465A patent/CH464935A/de unknown
- 1965-07-06 FR FR23661A patent/FR4491M/fr not_active Expired
- 1965-07-06 DE DE1620284A patent/DE1620284C3/de not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE1620284C3 (de) | 1974-10-24 |
| DE1620284B2 (de) | 1974-03-21 |
| FR4491M (enExample) | 1966-10-10 |
| DE1620284A1 (de) | 1970-03-12 |
| BE666424A (enExample) | 1966-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH513111A (de) | Verfahren zur Herstellung neuer Benz-epinderivate | |
| AT278846B (de) | Verfahren zur kontinuierlichen Herstellung von Isobutylidendiharnstoff | |
| CH474486A (de) | Verfahren zur Herstellung neuer Diphenylharnstoffe | |
| CH526579A (de) | Verfahren zur Herstellung neuer Benziodoxanderivate | |
| CH504426A (de) | Verfahren zur Herstellung neuer Bisnorcholanderivate | |
| AT279636B (de) | Verfahren zur Herstellung neuer Benzomorphanderivate | |
| CH519488A (de) | Verfahren zur Herstellung neuer 19-Nor-androstatriene | |
| CH476723A (de) | Verfahren zur Herstellung neuer Isoindol-Derivate | |
| CH446340A (de) | Verfahren zur Herstellung neuer Phenthiazinderivate | |
| CH467785A (de) | Verfahren zur Herstellung neuer Chinazolin-Derivate | |
| CH492725A (de) | Verfahren zur Herstellung neuer Chinazolinonderivate | |
| CH467789A (de) | Verfahren zur Herstellung neuer Diazepin-Derivate | |
| CH432538A (de) | Verfahren zur Herstellung neuer Yohimban-Derivate | |
| CH500972A (de) | Verfahren zur Herstellung neuer Spiro-azatetramethylen-Derivate | |
| CH467800A (de) | Verfahren zur Herstellung neuer Diazepin-Derivate | |
| AT256097B (de) | Verfahren zur Herstellung neuer Indolderivate | |
| AT310962B (de) | Verfahren zur Herstellung neuer 18-Methyl-5α-H-androstan-derivate | |
| CH462834A (de) | Verfahren zur Herstellung neuer 6-Hydrazino-pyridazin-Derivate | |
| CH467776A (de) | Verfahren zur Herstellung neuer Indol-Derivate | |
| AT261819B (de) | Verfahren zur Herstellung neuer Gonanderivate | |
| CH467793A (de) | Verfahren zur Herstellung neuer Ergolen-Derivate | |
| AT266106B (de) | Verfahren zur Herstellung neuer Nitrofuranderivate | |
| CH469005A (de) | Verfahren zur Herstellung neuer Ergolen-Derivate | |
| AT243813B (de) | Verfahren zur Herstellung neuer Azepinderivate | |
| CH512502A (de) | Verfahren zur Herstellung neuer Benz-epinderivate |